GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotechnology Assets SA (XMAD:BST) » Definitions » Total Liabilities

Biotechnology Assets (XMAD:BST) Total Liabilities : €10.08 Mil (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Biotechnology Assets Total Liabilities?

Biotechnology Assets's Total Liabilities for the quarter that ended in Dec. 2023 was €10.08 Mil.

Biotechnology Assets's quarterly Total Liabilities declined from Dec. 2022 (€14.60 Mil) to Jun. 2023 (€9.56 Mil) but then increased from Jun. 2023 (€9.56 Mil) to Dec. 2023 (€10.08 Mil).

Biotechnology Assets's annual Total Liabilities declined from Dec. 2021 (€15.54 Mil) to Dec. 2022 (€14.60 Mil) and declined from Dec. 2022 (€14.60 Mil) to Dec. 2023 (€10.08 Mil).

Biotechnology Assets Total Liabilities Historical Data

The historical data trend for Biotechnology Assets's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotechnology Assets Total Liabilities Chart

Biotechnology Assets Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.11 16.37 15.54 14.60 10.08

Biotechnology Assets Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.54 15.56 14.60 9.56 10.08

Biotechnology Assets Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biotechnology Assets's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.612+(5.154+1.309
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=10.08

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=16.607-6.532
=10.08

Biotechnology Assets's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.612+(5.154+1.309
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=10.08

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=16.607-6.532
=10.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotechnology Assets Total Liabilities Related Terms

Thank you for viewing the detailed overview of Biotechnology Assets's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotechnology Assets (XMAD:BST) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotechnology Assets SA (XMAD:BST) » Definitions » Total Liabilities
Comparable Companies
XMAD:ORY OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB RPRX LEGN
Traded in Other Exchanges
N/A
Address
Avenida del Desarrollo Tecnologico, No. 11, Scientific and Technological Park, Jerez de la Frontera, ESP, 11591
Website
https://www.biatgroup.com
Biotechnology Assets SA is a clinical-stage biopharmaceutical company developing and producing biological products for the pharmaceutical and veterinarian sectors. It specializes in the prevention and treatment of niche diseases, such as orphan disease, antigens for new-generation vaccines, feed additives, and probiotics. Adl Bionatur offers a portfolio of non-therapeutic and therapeutic products to tier 1 and tier 2 animal health companies. The company's pipeline products include BNT006, BNT007, BNT010, and others.